Zscaler (ZS) checks were "mostly positive" ahead of fiscal Q2 earnings next week with investors optimistic over its setup for the rest of the fiscal year, UBS said in an earnings preview emailed Tuesday.
The firm expects any commentary around sales productivity improvements, sales maturity, and participation in firewall displacement opportunities to be "positive."
Alternatively, the firm said it would keep an eye out for any updates on US federal spending given the broad downsizing, including the US Department of Defense.
UBS noted a "healthy debate" in conversations with investors over fiscal H2 billings, with analysts expecting 7% quarter-over-quarter growth in Q3, in contrast to 3% decline seen in the same period over the past four years, UBS said.
Still, the firm pointed to commentary by the company's management of a "significant H2 ramp" in contracted billings which would extend into Q3. As a result, the firm said it was estimating 5% quarter-over-quarter growth in Q3.
UBS kept its $250 price target for the company with a buy rating.
Price: 193.53, Change: -3.52, Percent Change: -1.79
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。